³X«È Åwªï±z!   ·|­ûµn¤J


 ¦^¥D­¶  ¡÷    Â卯*ÃÄ«~°Q½×ª©  ¡÷  ¥»½g¥DÃD¡G§Üºë¯«ÃĪ«¶·ª¾



 
¡i¤W¤@½g¡j[ ¤â³N«á¤îµh¶·ª¾ ] ¡i¤U¤@½g¡j[ ÃÄ«~¦³®Ä´Á­­ ]

    [¤À¨É]    §Üºë¯«ÃĪ«¶·ª¾

    mandy   µoªí©ó 2007/7/2 21:19:21



²¤¶ ©Ò¦³ÃĪ«³£·|¦ñÀH¦³°Æ§@¥Î¡C¤j¦h¼Æªº°Æ§@¥Î¬O¸û»´·Lªº¡A¹L¤@¬q®É¶¡´N·|§ïµ½¡C©Ò¥H¦b§A¶}©l¨Ï¥ÎÃĪ«ªvÀø¤§«e¡A­n¥ý©M§AªºÂå®v°Q½×¦³ÃöªvÀø©Ò¥i¯à³y¦¨ªº°Æ§@¥Î¡A¥]¬A°Æ§@¥Îµo¥Í®É­n¦p¦ó³B¸m¡A¦b¬Æ»òª¬ªp¤U¸Ó°±ÃĨåߧY´NÂå¡H¥»½g©Ò­n°Q½×ªº¬O¤@¨ÇªA¥Î§Üºë¯«¯fÃĪ«¸û±`µo¥Íªº°Æ§@¥Î¡C¥H¤U´N±`¨£°Æ§@¥ÎªºÁ{§É¯gª¬¤Î³B¸m¤èªk¤À§O´y­z¦p¤U¡G Pseudoparkinsonism¡]°²©Ê©¬ª÷´Ë¤ó¯g¡^ Pseudoparkinsonism¬O¥ÑªA¥Î§Üºë¯«¯fÃĪ«©Ò³y¦¨ªº«æ©Ê¹B°Ê»Ùꤧ¤@¡C¥ô¦ó®É¶¡³£ ¥i¯àµo¥Í¡A¤@¯ë±`¨£©óªì¥Î§Üºë¯«¯fÃĪ«ªºÀY¤@­Ó¤ë©Î½Õ¤É¾¯¶q«á¥X²{¡C°£¤F¥i«ì´_¥~¡A¦h¼ÆÁ{§É¯gª¬»P©¬ª÷´Ë¤ó¯g¬Û¦P(¥]¬AÂù¤â¥ð®§®ÉªºÅ¸§Ý¡BÂùÁu¦³¾¦½üª¬»øµw(cogwheel rigidity)¡B¹]ºÞ¯ëªº¬¡°Ê¤£ÆF¬¡¡B¦Ûµoªº¬¡°Ê´î¤Ö¡B°Ê§@¿ð½w¡B¬y¤f¤ô¡B­±µLªí±¡µ¥)¡C¥¦¬O¥i°fªº¡A¥u­n°±ÃÄ¡A¯gª¬´N·|®ø¥¢¡Cµo¥Íªº­·ÀIÀHµÛ¦~ÄÖ©M¨Ï¥Î¾¯¶q¦Ó¦³©Ò¤£¦P¡A³q±`¥H¦~¬ö¤jªº¤k©Ê¸û¬°±`¨£¡A¨Ï¥Î¾¯¶q¶V°ª­·ÀI¶V°ª¡C·s¤@¥N«D¨å«¬§Üºë¯«¯fÃĪ«²£¥ÍEPSªº¦MÀI©Ê¸û§C¡A¦³§Q©óµLªk§Ô¨ü¶Ç²Î§Üºë¯«¯fÃĪ«°Æ§@¥Î¤Î¦³¦¹°Æ§@¥Î°ª¦MÀI羣ªº¯f±w¥i¦Ò¼{¨Ï¥Î·s¤@¥N«D¨å«¬§Üºë¯«¯fÃĪ«¡CRisperidone¾¯¶q­Y>6mg/day²£¥ÍEPS­·ÀI¼W¥[¡C ·í¯f±w¦³pseudoparkinsonismµo¥Í®É¡A³B²z¤è¦¡¦p¤U¡G 1.­°§C§Üºë¯«¯fÃĪ«¾¯¶q¡C 2.­Y¦]¯f±¡µLªk­°§C¾¯¶q®É¡A¥i¥H¥[¤WantiparkinsonianÃĪ«¡C 3.­Y°Æ§@¥Î¤´µLªk§ïµ½¡A¥i¦Ò¼{§ï¥Î·s¤@¥N«D¨å«¬§Üºë¯«¯fÃĪ«¡C ¦p¦ó¿ï¥ÎAnticholinergic ÃĪ«©O¡H©Ò¦³Anticholinergic¹ïpseudoparkinsonism§¡¦³®Ä¡A¦ý¥L­Ìªº°Æ§@¥Î©M§@¥Î®É¶¡¤£ºÉ¬Û¦P¡CÄ´¦pTrihexyphenidylÂíÀR§@¥Î³Ì¤Ö¡FDiphenhydramineÂíÀR§@¥Î³Ì±j¡FBenztropine§@¥Î®É¶¡³Ìªø¡A¤@¤Ñ1~2¨â¦¸§Y¥i¡C­Yªø´Á¨Ï¥Î·|µo¥Í«K¯µ¡B¤f°®¡Bµø¤O¼Ò½k¡B§¿º¢¯d¡F¤×¨ä¹ï¦Ñ¤H®a¨Ó»¡¡A°O¾Ð¥i¯à¤]·|¨ü·l¡C¦¹¥~¦³¨Ç¯f±w·|¦]ªAÃīᦳ±¡ºü°ª©ù¤ÎªY§Ö·P¦Ó³y¦¨ÃĪ«ÀݥΡA¦ý³o³¡¤ÀªºÁ{§Éªí²{©¹©¹·|©MEPS²V²c¡AÂåÅ@¤H­û»Ý¯S§Oª`·N¡A¥HÁ×§K³y¦¨ÃĪ«ÀݥΡC TD¦b¨äÄY­««×¤ÎÁ{§Éªí²{¬O·|Åܤƪº¡A³\¦h­Ó®×¬O¥i«ì´_ªº¡C©Ò¥H¦³Ãöµû¦ô©M¶EÂ_ªºµû¶qªí¥²¶·¼Ð·Ç¤Æ¡CThe Abnormal Involuntary Movement Scale (AIMS)µû¦ôdyskinetic movement±q0-4¡A¨Ï¥Î¤W¤Q¤À²³æ¥B³Q¼s¬°±µ¨ü¡C¤£¹L¨Ã¤£¥u­­©ó§@¬°TD¶EÂ_¡C¦ÓDISCUS¥iµû¶qabnormal movementªº¦s¦b©MÄY­««×¤Î·í¶EÂ_©ú½T«áªº¨ä¥LÅܤơCDISCUS¦P®É¥i©ú½T´y­zTD ªº«¬ºA¥B¥i¤¹³\ÀH®É¶¡§ïÅܶEÂ_¡C¨Ò¦p¡G¼W¥[§Üºë¯«¯fÃĪ«¾¯¶q·|±»»\¦íTD¯gª¬¡C´î¤Ö§Üºë¯«¯fÃĪ«¾¯¶q©Î°±ÃÄ·|¦³withdrawal TD²£¥Í¡Cwithdrawal TD¦b1-3­Ó¤ë«á·|¦ÛµM®ø¥¢¡A­Y¯gª¬«ùÄò¶W¹L3-12­Ó¤ë«hºÙ¬°persistent TD¡C¥ý«e¦³persistent TDªº¯f±w·|µo¥Íremitted TD±¡§Î¡A¦ý³o¨Ç¯f±w¥Ø«e¨ÃµL¯gª¬¥BªvÀø¤]¨S¦³§ïÅÜ¡C ªø´Á¨Ï¥Î§Üºë¯«¯fÃĪ«ªº¯f±w»Ý¥Ñ¨ü¹L¨}¦n°V½mªºÁ{§É¤H­û¨C3-6­Ó¤ë¨Ï¥Î¼Ð·Çµû¦ôªí¦pAIMS©Î DISCUS°µdyskinesiasµû¦ô¡C´N©Ò±o¼Æ¾Ú¥[¥H°Q½×¥H½T«OÂåÀøªº³sÄò©Ê¤ÎÂåÀøªk«ß¤Wªº«OÅ@¡CDISCUS±o¤À¡Ù5ÄÝ©ó¦MÀI°T¸¹¡Aĵ¥ÜTD¥i¯à©Ê¸û°ª¡A»Ý°lÂܬO§_¦]antipsychotic¾¯¶q´î¤Ö³y¦¨ªºwithdrawal dyskinesias ©Î¬OTD«ùÄò¦s¦b¡C¦ý­Y«ùÄòantipsychotic¾¯¶qªvÀø¦ÓDISCUS«ùÄò¼W¥[¡A¨º»ò´N»Ý¶EÂ_¬°¥Ã¤[©ÊªºTD¡C ³B²zTD­º­«¹w¨¾¡C´N¬O§Üºë¯«¯fÃĪ«¥²»Ý¨Ï¥Î¦b¹ïÃĪ«¦³¤ÏÀ³ªº±¡ªp¡]¦pºë¯«¤Àµõ¯g¡B±¡·P©Êºë¯«¤Àµõ¯g¡B¦ñÀHºë¯«¯f¯gª¬ªº¼~Æ{¯gµ¥ºë¯«»Ùê¡^¥B¶·¨Ï¥Î³Ìµu®É¶¡³Ì¤p¾¯¶q¡C¦]¬°¦b¦­´ÁTD¬O¥i«ì´_ªº¡A©Ò¥H¦­´Á¶EÂ_¥XTD¹ï¨ä¡«á¬O«Ü¦³À°§Uªº¡CÃĪ«°²´Á¡]Drug holidays¡^¤£¦ý¤£¯à´î¤ÖTDªºµo¥Í¡A¤Ï¦Ó·|¨Ï¦MÀI©Ê¼W¥[¡C¦]¯f±w¤w¶EÂ_¥X¦³TD¡A©Ò¥H¥²¶·©M¯f±w°Q½×µû¦ô«ùÄò§Üºë¯«¯fÃĪ«ªvÀøªº§Q¹ú±o¥¢¡A¨Ã°O¸ü¦b¯f¾ú¤W¡C¨ä¦MÀI©Êªºµû¦ô¤D¬O®Ú¾Ú·í°±¤îÃĪ«ªvÀø®É¯f±w¹ï¨ä©Ò²£¥Íªº¤ÏÀ³¤§ºë¯«¯gª¬°µµû¦ô¡C¥²¶·±NÃĪ«¾¯¶q½Õ¾ã¦Ü¦³®Ä¤§³Ì¤p¾¯¶q¡A¦ýÁ×§K«æ³t­°§CÃĪ«¾¯¶q¥H¹w¨¾ÄY­«ªºwithdrawal dyskinesias¡C¦p¦¹«K¥i¥H´î¤ÖÃĪ«ªvÀø¾¯¶q©M²£¥Ídyskinesiaªº¦MÀI©Ê¡C ¹ï¤Ö¼ÆÄY­«TD­Ó®×¡A±M®a«ØÄ³¨Ï¥Î·s«D¨å«¬§Üºë¯«ÃĪ«¡C­YTDÄY­«©Î¬O¹ï¯f±w³y¦¨§xÂZ¥i¥H¨Ï¥Îclozapine©Î¤@ºØ·s«D¨å«¬ÃĪ«¥æ´À§@¬°²Ä¤@½uªvÀø¡C¥i¤fªAVit.E 800 IU ¤@¤Ñ¨â¦¸ªvÀø¡C¨ä¤§©Ò¥H¥i§ïµ½TD¡A¥i¯à¬O¦]¬°´î¤Ö¦Û¥Ñ°ò¤§¬G¡C¦ý¦¹¦b¦³TD¯gª¬¤Ö©ó5¦~¸û¬°¦³®Ä¡Crisperidone¡Ø6mg/day²£¥ÍTD¸û¨å«¬ÃĪ«¬°§C¡C¦Ó¥Brisperidone 6mg/day ¦Ü¤Ö¥i¼È®É§í¨îTD¯gª¬¡A¦ý¹ï¤w¦s¦bªºTDªø´Á©Ò³y¦¨ªº¼vÅTÁÙ¤£²M·¡¡C¦b¤ñ¸û¨Ï¥Îolanzapine»Phaloperidol¶W¹L7­Ó¤ë¡Adyskinetic movement¯gª¬¥X²{²volanzapine©úÅã¸û¤Ö¡C¥Ñ©ó¯Ê¥F¦³Ãöolanzapine¡Brisperidone¡Bziprasidone¡Bquetiapineªø´Á¼Æ¾Ú¡A©Ò¥H¦b³o¨ÇÃĪ«¹ê»ÚTDµo¥Í²v¡A»Ý­nªá³\¦h¦~¤~·|ª¾¹D¡C





   µoªí¥DÃD ¦^ÂÐ¥DÃD

    mandy  ¦^ÂЩó  2007/7/2 21:19:36



Acute Dystonia¡]«æ©Ê¦Ùºò±i²§±`¡^ «æ©Ê¦Ùºò±i²§±`¬OEPS¤¤³Ì¦­µo¥Íªº¡C¦h¼Æ¦b­è¶}©lµ¹ÃĩμW¥[¾¯¶qªºÀY´X¤Ñµo¥Í¡C¨ä²{¶H¥]¬A¦ù¦ÞÀY¡B²´²y¤W¦Q¡B±×ÀV¡B¤úÃöºò³¬¡B¤Î¨­Åé¡B¥|ªÏ¡B¸}³k«º¶Õ²§±`¡C¯S§O¬O¨Ï¥Î°ª®Ä¯à§Üºë¯«¯fÃĪ«¦b¦~»´¨k©Êµo¥Í¦¹°Æ§@¥Î¾÷²v³Ì°ª¡C«æ©Ê¦Ùºò±i²§±`¬Odopamine¨t²Î²§±`¡A¦b¬ðµMªA¥Î§Üºë¯«¯fÃĪ««á³y¦¨¯«¸g¶Ç¾Éª«½è¤£¥­¿Å©Ò³y¦¨ªº¡Cacute dystonia¶·¥ß§Y³B¸m¡B½w¸Ñ¡A§Y¨Ï¦¹°Æ§@¥Î·|¦Û¦æ½w¸Ñ¦ý¹ï©ó¯f±wªº¤£¾A©M·ÓÅUªÌ³£·|¦³¤£·íªºÁp·Q¡Cªì´ÁªvÀø¥Ø¼Ð¬°benztropine 1~2 mg©Îdiphenhydramine 25~50 mg IM¾¨§Ö¨Ï¯gª¬½w¸Ñ¡C­Y15~30¤À¤´µLªk½w¸Ñ¯gª¬¡A¦A­«½Æµ¹»P¡C­Y¹ïanticholinergics¦³¸T§ÒªÌ¡A«hµ¹»Plorazepam 1~2 mg IM¡C¦P®É­n¦V¯f±w»¡©ú³o°Æ§@¥Î¬O¼È®É©Êªº¡A¬O¥i¥H¹w¨¾¤ÎªvÀøªº¡C¦bµo¥Í«æ©Ê¦Ùºò±i²§±`«á¡A¥iµ¹»P¤fªAanticholinergics 2 ¬P´Á¡A¹w¨¾Pseudoparkinsonismµo¥Í¡C Akathisia¡]ÀR§¤¤£¯à¡^ Akathisiaªº¯g­Ô¸s¥]¬A¥DÆ[ªº·Pı¦³µJ¼{¡B¤£¦w¡BµLªkÀR¤î¤U¨Ó¡B·Pı¿Ç¤l¤º¦³¿ÂÃÆ¡F »P«ÈÆ[徴¶H¦³¿â¨B¤£°±¡B·n°Ê¤£°±¡A¥BµLªkªø®É¶¡¦b¤@­Ó¦a¤è§¤©Î¯¸¡CAkathisia ·|¼W¥[§ðÀ»©Ê¡A¥B¬OªAÃͶ±q©Ê®tªº¥D­n­ì¦]¡A»PPsychomotor agitation ©M psychosis ´c¤Æ«ÜÃø¿ë§O¡C³q±`¦b¶}©lªA¥Î§Üºë¯«¯fÃĪ«ªvÀøªº«e´X¤Ñ¦Ü«e´X¬P´Áµo¥Í¡Cµo¥Í®É¥i¥H¥ý­°§Cantipsychotic¾¯¶q¡A­Ypsychosis¦A¥X²{©Îakathisia¤´¦s¦b¡A¥i¥[¤W£]-blockers¡Banticholinergics¡B§C¾¯¶qlorazepam©Îclonazepam¡C­º¿ïÃĪ«¬°propranolol¡]30~90mg/day¡^¡C¶}©l®Épropranolol 20mg tid¡A¨C2¤Ñ¥[20mg¡A³Ì°ª¥[¨ì120mg¡C­Y120mg/dayªvÀø¤@¬P´Áakathisia¤´«ùÄò¡A«h¥i¸Õbenzodiazepines©Î§ï´««D¨å«¬§Üºë¯«¯fÃĪ«¡C Tardive Dyskinesia(TD)¿ðµo©Ê¹B°Ê§xÃø TD¬O¦]ªø´ÁªA¥Î§Üºë¯«¯fÃĪ«©Ò¤Þ°_ªº¤@ºØ«ùÄò¥B¤£¦Û¥D©Ê¹B°Ê¹L«×ªº¤£¥¿±`°Ê§@ªº¯g­Ô¸s¡C¥]¬AÁy¡]©âÝz¡B¯w²´¡B§ê°­Áy¡^¡B¦ÞÀY¡]©CÄZ¡B±À¥X¡BŸ§Ý¡B§á¦±¡^¡B®B¡]Ëß¼L¡BÁYÃl¡Bäþ¼L¡^¡BÀV³¡©MÂß·F¡]§á¡Btorticollis¡^¡B¥|ªÏ¡]¸}³k»´ºV¡Bpill rolling¡B§á¦±¡^¡C©I§l¤£³W«h¡B©BÂP©BÂPÁn¡B¥´ÜСCÄY­««×¨C¤Ñ·|¦³ÅܰʡA³q±`ºÎı®É·|¸û½w©M¡C ªA¥Î§Üºë¯«¯fÃĪ«ªº¯f±w¬ù15~20%·|µo¥ÍTD¡C³q±`¦bªvÀø«e5¦~µo¥Í¾÷²v³Ì°ª¡C¦³¨Ç­Ó®×TD¬O¥i«ì´_ªº¡C¬ù60~70%¬OÄÝ»´·Lªº¡A¥u¦³3%ÄY­«¨ì·|³y¦¨©I§l¡B§]Ã`¡B»¡¸Ü§xÂZ¡A©Î¬O¥~»ªÅÜÁà¡CTDµo¥Í²v©M¤£¥i«ì´_ªº­·ÀI·|ÀHµÛ¦~ÄÖ¦Ó¼W¥[¡C¬ù¦³70%¨Ï¥Î§Üºë¯«¯fÃĪ«ªº¦Ñ¤H·|¦³TD¡C¤k¤H¬O¨k¤Hªº¨â­¿¡CªvÀø¾¯¶q¤j©M®É¶¡ªø¤]¸û©ö²£¥ÍTD¡C¦³ÄY­«©M«æ©ÊÀ@Åé¥~¯g­Ô¸sªº¯f¤H²£¥ÍTD­·ÀI¸û°ª¡C©Ò¦³¶Ç²Î§Üºë¯«¯fÃĪ«³£·|³y¦¨TD¡C §ÜÁxÆPÃĪ«©MTDªºÃö«Y¤Q¤ÀÀǬN¥B¬Û½Ä¬ð¡C¹L¥h»{¬°§ÜÁxÆPÃĪ«·|³y¦¨TD¡A²{¦b«h»{¬°TD¨Ó¦ÛÃĪ«©Ò­PªºÄY­««æ©ÊÀ@Åé¥~¯g­Ô¸s°Æ§@¥Î¡A¦Ó¨Ã«DªvÀøEPSªº§ÜÁxÆPÃĪ«¡C¿ðµo©Ê¦Ùºò±i²§±`¡]tardive dystonia¡^¬°TDªº¤@ºØ¡AanticholinergicsªvÀø¦³®Ä¡A¦ý¨ä¥L«¬ºAªºTD«h·|´c¤Æ¡CÁ`¦Ó¨¥¤§¡Apseudoparkinsonism©MTD·|¨Ã¦s¡A©Ò¥HÄ~ÄòanticholinergicsªvÀø¬O¦³¥²­nªº¡C ¯u¥¿³y¦¨TDªº­ì¦]¤£²M·¡¡C®Ú¾Údopamine-receptor hypersensitivity ²z½×¡Aªø´Á§Üºë¯«¯fÃĪ«ªvÀø«á¡A¦bnigrostriatal °Ï°ìpostsynaptic dopamine-receptor ¿@«×¼W¥[¡A³y¦¨¸£³¡±±¨î¹B°Êªº°Ï°ìdopamine¥\¯à¹L°ª¡C¦ý¦º«á¸Ñ­å¬ã¨s«h¤£¤ä«ù³oºØ»¡ªk¡C¼W¥[§Üºë¯«¯fÃĪ«¾¯¶q¦bÁ{§É¤W·|±»»\TD¯gª¬¡A­°§C¾¯¶q«hµLªk±»»\TD¡A©Ò¥Hdopamine¦bTD¤W¥i¯àÁÙ¬O§êºt³¡¤À¨¤¦â¡C¾ãÅé¦Ó¨¥TD¥i¯à¬O¥Ñ³\¦h¦]¯À³y¦¨ªº¡A¥]¬A¤£¥u¤@ºØ¯«¸g¶Ç¾Éª«½è¦³¥\¯à»Ùê¡C¦]¬°TD¯f¤Hdopamine £]-hydroxylase ©M norepinephrine ªº¿@«×¸û°ª¡A©Ò¥Hnoradrenergic ¥\¯à¨ü·l¤]¬O¥i¯à­ì¦]¤§¤@¡C¦ý¬O¦b©ú½T¶EÂ_TD¤§«e¤´»Ý°µ§ó¶i¤@¨Bªºµû¦ô¡C





   µoªí¥DÃD ¦^ÂÐ¥DÃD

    mandy  ¦^ÂЩó  2007/7/2 21:20:05



Lithium ¹ï©ó§Üºë¯«¯fÃĪ«µL¤ÏÀ³ªººë¯«¤Àµõ¯g±wªÌ¡A¬ù¦³50%¥i¥Î¦¹ÃĪ«Àò±o±¡ºü¤W¤Îºë¯«¯f©Ê¯gª¬ªº§ïµ½¡C»P§Üºë¯«¯fÃĪ«¨âªÌ¦X¥Î¬O§_·|¼W¥[¯«¸g¬r©Ê¤´¥¼¦³©w½×¡C Benzodiazepines ¥D­n¥Î©ó«æ©Ê´Áªº¿E°ÊµJ¼{¤Î§ïµ½¯f±wºÎ¯v»Ùê»PµJ¼{ªº¯gª¬¡A¹ï©óºë¯«¯f©Ê¯gª¬¬O§_¦³§ïµ½®ÄªG¡A¦³ªº¬ã¨s»{¬°¦³¡A¦³ªº»{¬°¨S¦³¡CEx:Alprazolam(Xanax) 5mg/day(10#) 4 weeks¥i¥H§ïµ½¤j¬ù¤@¥b¯f¤Hªº¤ÛÅ¥¡B¦k·Q¡AµLªk¨M©w­þ¨Ç¯f¤H·|¦³®ÄªG¡A¥²¶·µû¦ô¦¹ºØÃĪ«ªºÀݥΤίf¤H­YÃĪ«ªA±q©Ê(compliance)¤£¨Î®É·|³y¦¨¸TÂ_¯gª¬¡A¬G¦Ò¼{¸Õ¥Î2~4¶g©ó¹ï§Üºë¯«¯fÃĪ«¤ÏÀ³¤£¨Î¡A¨S¦³ÀÝ¥ÎÃĪ«¤Î¤H®æ²§±`¯f¥vªº¯f¤H¡C Propranolol (Inderal) ¹ï©ó§Üºë¯«¯fÃĪ«ªvÀø¤ÏÀ³¤£¨Îªº¯f¤H¡A¨Ö¥Î¦¹Ãĩγ\¦³¤ÏÀ³¡C¥¦¥i¥H¼W¥[§Üºë¯«¯fÃĪ«ªº§@¥Î¡A¥i¯àªº­ì¦]¬OÃĪ«ªº¥æ¤¬§@¥Î³y¦¨§Üºë¯«¯fÃĪ«¦å¤¤¿@«×¸û°ª¡C¥t¥~¥i¯à¹ïºC©Êªº¯fµ{´c¤Æ¦³§@¥Î¡C³q±`¥i¥Î°ª¾¯¶q¡A¯f¤H¥i¥H§Ô¨ü¡A¨Ò¡G40~80mg twice a day , increased every other day until intolerable side effects occur ¡]¦¬ÁYÀ£<90mm Hg or a heart rate <50 beats /min¡^¡C¥i±q160mg¥Î¨ì1920mg¡A³q±`¦Ü¤Ö­n240mg/day¨Ï¥Î2­Ó¤ë Carbamazepine (Tegretol) ¹ï§Üºë¯«¯fÃĪ«µL¤ÏÀ³ªº¯f¤H¡A¨Ï¥Î¦¹Ãĩγ\¥i¥H§ïµ½¿E°Ê¤Î§ðÀ»©Ê¡A¦ý¬ã¨sÅã¥Ü¨ä®t§O¦³­­¡A©Ò¥H¥u¦³¦b«e­±´XºØÃĪ«³£µL®Ä«á¤~¹Á¸Õ¨Ï¥Î¡A©ÎªÌ¬O¯f¤H«D±`¤£Ã­©w©Î¨Öµoļ¯gªÌ¨Ï¥Î¡C ¡@ ¡@¡@§Üºë¯«¯fÃĪ«ªº°Æ§@¥Î¤ÎªvÀø À@Åé¥~°Æ§@¥Î(Extrapyramidal side effects, EPSEs) (1) ¤Úª÷´Ë¤ó¯g­Ô¸s(Pseudo-parkinsonism)¡G ¬ù¤­¤À¤§¤@¯f¤H·|¸gÅ禹°Æ§@¥Î¡A³Ì±`¨£¡C³q±`¦bªvÀø¹Lµ{¤¤³vº¥¥X²{¡A·|¦³Å¸§Ý(tremor)¡B°Ê§@ºC(bradykinesia)¡B»øµw(rigidity)¡B¤f¤ô¥~¬y(sialorrhea)µ¥Ãþ¦ü¤Úª÷´Ë¤ó¯g­Ô¸sªº¤ÏÀ³¡AªvÀø¤èªk¦³¡G­°§C§Üºë¯«¯fÃĪº¥Î¶q¡A¨Ï¥Î§Ü¤Úª÷´Ë¤ó¯gªºÃĪ«( trihexyphenidyl ,benztropine )¡Bdiphenhydramine ( ¥ç¦³anticholinergicªº§@¥Î¡A¥B³Ì¨ãsedative ) (2) «æ©Ê¦Ù±i¤O¤£¥þ(Acute Dystonia) ¦nµo©ó¦~»´­Ó®×¡A¨k©Ê¦h©ó¤k©Ê¡C¦b¶}©l¥ÎÃĩνհª¾¯¶qªº²Ä¤@­Ó¬P´Á¥X²{¡A¯gª¬¬°¾î¯¾¦Ù¤£¥¿±`¦a¦¬ÁY¡A¤×¥HÀYÀV³¡¦Ù¦×§ó±`¨£¡A¦p²´²y¤W¦Q¡B¦ÞÀY¥~¦R¡B±²¦Þ¡B§]¦Þ¡B¤úÃöºò³¬¡B¤U¤Ú±×¤@Ãä¡BÀV³¡«á¥õ©Î¬n±×¡A¬Æ¦ÜÂß·F§á¦±µ¥µLªk¦Û¥Dªº°Ê§@¡AÄY­«ªÌ¬Æ¦Ü¼vÅT§]Ã`¤Î©I§l¡C¥i¥ÎBenztropine 1~2mg or diphenhydramine 25~50mg, IM or IV.µ¥¨ÓªvÀø¡A¥t¥i¤fªAanticholinergics ¨â¶g¨Ó¹w¨¾¦¹ºØ¯gª¬¦Aµo¥Í¡C (3) ÀR§¤§xÃø(Akathisia) ¬O§_ÄÝ©óEPSs¤´¦³ª§Ä³¡A¦¨¦]¤F¸Ñ³Ì¤Ö¡A¥i¯à¸òadrenergic system¦³Ãö¡C©ó¥ÎÃÄ«á¼Æ¤Ñ¦Ü¼Æ¶gµo¥Í¡A¯f¤H¥DÆ[ªºÄ±±o«D±`µJ藍¦w¡Aºë¯«­n±Y¼ìªº·Pı¡A¦Ó¥B·|§¤¥ßÃø¦w¡A¤@ª½°Ê­Ó¤£°±¡CªvÀø¥i¥ÎBeta-blocker (propranolol 30~120mg/day)¡BBenzodiazepines ( lorazepam,clonazepam )¡A°±¥Î©Î­°§C§Üºë¯«¯fÃĪ«ªº¾¯¶q¤]¥i§ïµ½¡C (4) ¿ðµo©Ê¤£¦Û¥D¹B°Ê(Tardive Dyskinesia, TD) ¦~¬ö¤j¡B¤k©Ê¸û©öµo¥Í¡A³q±`«ùÄò¨Ï¥Î§Üºë¯«¯fÃÄ¥b¦~¥H«áµo¥Í¡A¬Æ¦Ü¼Æ¦~«á¤~¥X²{¡A¦ý¤]¦³3~4­Ó¤ë´N¥X²{¦¹°Æ§@¥ÎªÌ¡CÄݩ󤣳W«h¤§¤£¦Û¥D°Ê§@¡A³Ì±`¨£©ó©CÄZ¦Ù¦×¡£¦Þ¡B®B¤Î©CÄZ¬ÛÃöÁy³¡¦Ù¦×¡¤¡A¤]¥i§e²{¤£¦í¯w²´¡AÂß·F§á¦±©Î¤â¸}¤£³W«h°Ê§@¡C¥Ø«eµL¦³®ÄªvÀø¤èªk¡A°±¥Î§Üºë¯«¯fÃĤ]¤£¤Ó¯à§ïµ½¦¹°Æ§@¥Î¡C §Üºë¯«¯fÃÄ´c©Ê¯g­Ô¸s(Neuroleptic Malignant Syndrome, NMS) ¤Ö¨£¡A¦ý·¥¬°ÄY­«¡A24~72¤p®É¤º«æ¼@´c¤Æ¡A¦º¤`²v¥i¹F15-30%¡C¥X²{µo¿N(41¢XC)¡BÄY­«EPS¡B¦Ù¦×»øµw¡A¦ñÀH¦Û¥D¯«¸g¨t²Î¥¢½Õ²{¶H¡G¤j¶qµs¦½¡B©I§l¡B¤ß¸õ¡B¦åÀ£¤£Ã­©w¡A·NÃѤ]·|¦³»Ùê¡C·|¦³Creatine kinase (CK)¡BWBC count increaseªº²{¶H¡A¦ý¨Ã«D¶EÂ_ªº¥²­n±ø¥ó¡C¶·°±¤î§Üºë¯«¯fÃĪ«¡A±Ä¥Î¤ä«ùÀøªk¡Aµ¹¤©¸û±jªº°©Àf¦ÙÃP¦¢¾¯ (¨Ò¡Gdantrolene)¡Aªñ¦~µo²{µ¹¤©dopamine agonists (amantadine, bromocriptine ) ¥ç¦³§U¯q¡C Hematological Adverse Effect 0.8%ªº¯f¤H·|¦³WBC¼È®É¤U­°ªº²{¶H¡Aagranulocytosisªºµo¥Í²v«Ü¤p¡£clozapine¨Ò¥~¡¤¡A¦Ó¥B³q±`·|µo¥Í¦bÀY¤@­Ó¤ë¡C ³¬¸g¤Î·¸¨Å(Amenorrhea and Galactorrhea) ¥i¥Îdopamine agonist (bromocriptine, amantadine)¡A³q±`¥i¦b¥b­Ó¤ë«á§ïµ½¡C Hepatic Dysfunction Chlorpromazine¸û¬°ÅãµÛ¡A¬ù¦³1-2%ªº¯f¤Hµo¥Í¡A¦hµo¥Í©ó¥ÎÃÄ«á²Ä¤@¶g¡A¯gª¬»´·L¡A³q±`2-8¶g«á´N·|§ïµ½¡A¥i¦Ò¼{§ï¥Î¨ä¥LÃĪ«(¤×¨ä¬OnonphenothiazineÃþ) Temperature Dysregulation and Dermatological Effects Temperature Dysregulation¥i¯à¬O¥Ñ©ó§í¨î¤Uµø¥CÅé·Å½Õ¸`§@¥Î³y¦¨¡C ¦³¨Ç¯f¤H·|¦³¥Ö½§¹L±Ó²{¶H¡A¯SÂI¬O¤é¥ú·Ó®g³¡¦ì¸û¬°ÄY­«(¥ú±Ó·P²{¶H)¡C¦]¬°ºë¯«¯fÃĪ«¤TÀôªºµ²ºc·|§l¦¬µµ¥~½u¡A²£¥Í¤F®e©öÅζˡB²£¥Í¤£¥¿±`ªº¦â¯À¨I¾ý¡B¯l¶ô¡A©Ò¥H­n±Ð¾É¯f¤H°µ¦n¨¾ÅΪº¤u§@¡A­Y¤w²£¥Í³o¼Ëªº°Æ§@¥Î¡A¥i¥Îantihistamine¡A­Y«ÜÄY­«¡A·íµM­n°±ÃÄ¡Clow potency ¤j¾¯¶q¸û©öµo¥Í¦¹°Æ§@¥Î¡C Ocular Effects ¸ò¥Ö½§ªº¥ú±Ó·P¤ÏÀ³¬Û¦P­ì¦]¡Alow potency¤j¾¯¶qªA¥Î¥i¯àµo¥Í²´²y¨¤½¤¡B¤ô´¹Åé¡Bµøºô½¤¦â¯À¨I¿n Sexual Dysfunction ¥i¯à¦b©Ê¤ÏÀ³ªº¦U¶¥³y¦¨§í¨î§@¥Î¡A¥]¬A©Ê¼¤­°§C¡B©Ê°ª¼é´î¤Ö¡B¨k©Ê«k°_¡B®gºë»Ùêµ¥¡Athioridazine³Ì±`¨£¡A¦³¦hºØ¥i¯à³y¦¨¦¹°Æ§@¥Îªº§@¥Î¾÷Âà(sedative, alpha-adrenergic¡K)¡Aºë¯«¤Àµõ¯g¥»¨­¥i¯à¤]·|³y¦¨©Ê¥\¯àªº°ÝÃD¡A¬G¶·¿ë§O¡]¨Ò¦p°±¥ÎÃĪ««á¬O§_¦³§ïµ½¡C¡^ Seizures Low potency¸û©öµo¥Í¡A¤×¨ä¬Ochlopromazine¡A¨ä¦¸¬Otrifluoperazine, perphenazine¡Fthioridazine, molindone, fluphenazine, haloperidol³Ì§C¡Aclozapine¤]¦³¤Þµoªº¥i¯à©Ê¡C¦³Åöíw¯f¥vªº­Ó®×¡AÁ×§K¨Ï¥Î¤j¾¯¶q¡A¥i¦X¨ÖBD¨Ï¥Î¨Ï¾¯¶q­°§C¡C Weight Gain ³q±`¦bÀY12¶g¡A¤j¬ù·|¼W¥[3-9½S¡C³y¦¨ªº­ì¦]¤]¬O«Ü¦h¡AÃĪ«¥u¬O¨ä¤¤¤§¤@¡A¨ä¥L¥i¯àªº­ì¦]¥]¬A¡G¹ï­¹ª«ªº°¾¦n§ïÅÜ¡A­¹¶q¼W¥[¡A¯Ê¥F¹B°Ê¡C°ß¤@ªºªvÀø¤èªk¬O¡G¹B°Ê¡B­­¨î¶¼­¹¡C Psychogenic Polydipsia ¤j¶q¶¼¤ô (polydipsia)(¨C¤é±µªñ 10 ¤É)©Î¤j¶q¶¼¤ô¦æ¬°¤Î¤ô¤¤¬r (water intoxi-cation )¡B§C¦å¶uªº²{¶H±`¦bºC©Êºë¯«¯f±w¡A¯S§O¬Oºë¯«¤Àµõ¯g±wªÌ¤¤¥X²{¡A¦¹¤@²{¶H¥i¯à±a¨Ó¬Û·íÄY­«¤§¨Öµo¯g¡A¦pļ°Ê¡BµjÅË¡B©ü°g¡C¤j¶q¶¼¤ô¦æ¬°ªº¦¨¦]¡A¦Ü¤µ¤´¥¼¦³©w½×¡A¦ý¨ä­«­n©Ê¦bªñ¤Q¦~¨Ó³vº¥¨ü¨ì­«µø¡C¦­´Á»{¬°¬O¾YÆQ©Î§Üºë¯«ÃĪ« ¤Þ°_¤f´÷¤§°Æ§@¥Î¡A¦ý¦¹Æ[ÂI¥Ø«e»á¨ü½èºÃ¡C¦³¾ÇªÌ»{¬°¥i¯à¬O¤Uµø¥C©Î®ü°¨°jªº¥\¯à»Ùê©Ò¤Þ°_¡A¤Ûı¤Î¤ß²z¦]¯À¬°­«­n¦]¯À¡C¥t¥~¦³¾ÇªÌ«ü¥X¦¹Ãþ±wªÌ¦h¦X¨Ö·ÏÅ}¨Ã´£¥X¨ä¦¨¦]¥i¯à¦]¬°¥§¥j¤B¨ë¿Evasopressin©Ò¤Þ°_¡C¤]¦³¬ã¨sµo²{¤ô¤¤¬r¤§ºC©Êºë¯«¤Àµõ¯g¯f±w°sÅ}¤ñ²v¸û¹ï·Ó²Õ¬°°ª¡A¦Ó´£¥X¤ô¥ç¥i¯à¬°³QÀݥΪ«½è¤§·§©À¡C ¡@¥Íª«©ÊªºªvÀø°£ÃĪ«ªvÀø¥~¡A¥t¦³¹qµjÅ˪vÀø¡A¥D­n°w¹ïÃĪ«ªvÀø¤ÏÀ³¤£¨Î¡A¹ïÃĪ«°Æ§@¥ÎµLªk§Ô¨üªº¯f¤H¡A¦b«æ©Êµo¯f©Î´c¤Æ®ÉªºªvÀø¡A¤@¯ë¦Ó¨¥¡A¹qµjÅ˪vÀø¹ïºë¯«¤Àµõ¯gªº¸Ñ²Õ¡B¿E°Ê¡A¤Îºò±i©Ê¯gª¬ªºªvÀø®ÄªG¸û¨Î¡C ¡@¡@¥Ñ©óºë¯«¤Àµõ¯g¬O¤@ºØºC©Êªººë¯«¯e¯f¡A¦bº©ªøªº¯fµ{¤¤¡A»Ý­n¦³¨}¦nªº±¡ºü¡B®a®x¤ÎªÀ·|ªº¤ä«ù¡A¦]¦¹ªvÀø»Ý¥]¬A­Ó§O»P¹ÎÅ骺¤ß²zªvÀø¡BªÀ·|ªºªvÀø¤Î´_°·¡C ¡@¡@­Ó§O¤ß²zªvÀøªº­«ÂI¦b¤ä«ù©ÊªºªvÀø¡A¥]¬A±¡ºüªº¤ä«ù¡A§ïµ½µJ¼{¡B®£Äß¡B¥¢¯v¡A¯e¯fªº½Ã±Ð»P¾AÀ³¡A¥Í¬¡¡BÃĪ«¡B¤u§@¡B®a®xªº¿Ô¸ßµ¥¡C¹ÎÅé¤ß²zªvÀøªº­«ÂI«h¦b©ó±¡ºüªº¤ä«ù¡B¯e¯fªº¾AÀ³¡A¤H»Ú¤¬°Êªº¼W¶i¡AªÀ¥æ§Þ¥©ªº°V½mµ¥¡C ¡@¡@¥Ñ©óºë¯«¤Àµõ¯gªº®aÄÝ­t¾á³\¦h·ÓÅU¯f¤Hªº³d¥ô¡A¦]¦¹®a®xªºªvÀø¤]¬Û·í­«­n¡A­«ÂI¥D­n¦b¹ï®aÄݽñЯe¯f»PÃĪ«¡A±¡ºüªº¤ä«ù¡A´î¤Ö°ª±¡ºüªíÅS¡£¼Ä·N¡B§åµû¡B¹L«×«OÅ@»P¤z¯AªººA«×¡¤¡A¦p¦ó·ÓÅU¯f¤Hªº¿Ô¸ßµ¥¡C ¡@¡@ºë¯«¤Àµõ¯g©M¤@¯ë¯e¯f¤£¦P¡A¥Ñ©ó¯fªº¥»¨­ÁÙ·|¼vÅT¨ìªÀ·|¥Í¬¡¥\¯à°h¤Æ¡A©Ò¥H¥²¶·±µ¨ü´_°·ªvÀø¤~¯à«ì´_ªº§ó¦n¡C´_°·¦bÀ°§U¯f¤H­««ØªÀ·|¥i±µ¨üªº¦æ¬°¡A¾AÀ³ªÀ·|¥Í¬¡¦Ó­«ªðªÀ·|¡A³z¹L¦³·N¸q¡B¦³¥Øªºªº¬¡°Ê¹F¨ìªvÀø»P´_°·ªº¥Øªº¡C ¡D¹ê¥Îºë¯«Âå¾Ç¡G¥x¤jÂå¾Ç°|¥Xª©¡A§õ©úÀØ¥D½s ¡DApplied Therapeutics¡GThe clinical use of drugs¡A7th edition





   µoªí¥DÃD ¦^ÂÐ¥DÃD

¦@  1  ­¶    ¥Ø«e  1      «e©¹¡G  ¿é¤J¼Æ¦r«öEnter

¤ý®v¤÷±M·~Àð¾À¤Á¤ÕÆp¤Õ¤Þ¤Õ¤uµ{ªA°È
¥x¥_Æp¤Õ¤Á³Î ¤T­«Æp¤Õ¤Á³Î
ªO¾ôÆp¤Õ¤Á³Î ·s²øÆp¤Õ¤Á³Î
Àð¾ÀÆp¤Õ¤Á³Î,Àð­±¤Þ¤ÕÆp¤Õ,¦aªOÆp¤Õ¤Á³Î

[±ÀÂ˵û»ù¦n©±] - 4C§Ö­×³sÂêªù¥« ±M·~ºû­×¶R½æ-µ§¹q+¤â¾÷+¹q¸£+Iphone+Ipad
·s¥_¦Á¤î©± (02) 7751-9182
·s¥_¥«¦Á¤î°ÏºÖ¼w¤@¸ô86«Ñ22¸¹
·s¥_ªO¾ô©± (02) 8257-3990
·s¥_¥«ªO¾ô°Ï¥|ºû¸ô137«Ñ10¸¹
®ç¶é¤j·Ë©± (03) 387-4353
®ç¶é¥«¤j·Ë°Ï¤¤µØ¸ô210¸¹
¥x¤¤¥«°Ï©± (04) 2201-1289
¥x¤¤¥«¤¤°Ï¥x¤¤¸ô140¸¹


   ¥xÆWÂåÀø½×¾Â ¦^³»ºÝ
¦Û¾AÀ³ºô­¶½d¥»


³sµ²Àu¨}¸ê°T¤J¤fºô ¥»¯¸¤J³ò½Ã¥Í¸p95¦~«×Àu¨}°·±d¸ê°Tºô¯¸ ¥xÆWÂåÀøºô © 2006 Taiwan Inc. All Rights Reserved.

*«ØÄ³IE5.0¥H¤W¤§ÂsÄý¾¹ ¸ÑªR1024*768 ¥H¹F³Ì¨ÎÂsÄý®ÄªG* ¥þ¯¸¨Ì¤º®e¤À¯Å³W©w³B²z